$5.62
0.428.08%
Pre-Market: Nov 18, 9:25 AM EDT
Comments
Loading...
Molecular Partners (MOLN) Forecast
NewsEarningsMolecular Partners (MOLN) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestMolecular Partners (NASDAQ:MOLN) Stock Quotes, Forecast and News Summary
Molecular Partners Stock (NASDAQ: MOLN) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Molecular Partners (MOLN) stock?
You can purchase shares of Molecular Partners (NASDAQ:MOLN) through any online brokerage.
Who are Molecular Partners (MOLN) competitors?
Other companies in Molecular Partners’s space includes: Macrogenics (NASDAQ:MGNX), Zura Bio (NASDAQ:ZURA), Galectin Therapeutics (NASDAQ:GALT), Inozyme Pharma (NASDAQ:INZY) and Adaptimmune Therapeutics (NASDAQ:ADAP).
What is the forecast, or price target, for Molecular Partners (MOLN) stock?
Molecular Partners has a consensus price target of $6.25.
What is the current price for Molecular Partners (MOLN)?
The stock price for Molecular Partners (NASDAQ: MOLN) is $5.62 last updated November 18, 2024 at 9:25 AM EST.
Does Molecular Partners (MOLN) pay a dividend?
There are no upcoming dividends for Molecular Partners.
When is Molecular Partners (NASDAQ:MOLN) reporting earnings?
Molecular Partners’s H1 earnings are confirmed for Monday, August 26, 2024.
Is Molecular Partners (MOLN) going to split?
There is no upcoming split for Molecular Partners.
What sector and industry does Molecular Partners (MOLN) operate in?
Molecular Partners is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.